166 related articles for article (PubMed ID: 16218916)
21. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
22. Pretangles and neurofibrillary changes: similarities and differences between AD and CBD based on molecular and morphological evolution.
Uchihara T
Neuropathology; 2014 Dec; 34(6):571-7. PubMed ID: 24612177
[TBL] [Abstract][Full Text] [Related]
23. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.
Maeda S; Sahara N; Saito Y; Murayama S; Ikai A; Takashima A
Neurosci Res; 2006 Mar; 54(3):197-201. PubMed ID: 16406150
[TBL] [Abstract][Full Text] [Related]
24. Tau in aluminum-induced neurofibrillary tangles.
Singer SM; Chambers CB; Newfry GA; Norlund MA; Muma NA
Neurotoxicology; 1997; 18(1):63-76. PubMed ID: 9215989
[TBL] [Abstract][Full Text] [Related]
25. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
26. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
Uematsu M; Nakamura A; Ebashi M; Hirokawa K; Takahashi R; Uchihara T
Acta Neuropathol Commun; 2018 Jan; 6(1):1. PubMed ID: 29298724
[TBL] [Abstract][Full Text] [Related]
27. Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field.
von Gunten A; Kövari E; Rivara CB; Bouras C; Hof PR; Giannakopoulos P
Exp Neurol; 2005 May; 193(1):198-206. PubMed ID: 15817278
[TBL] [Abstract][Full Text] [Related]
28. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
van de Nes JA; Sandmann-Keil D; Braak H
Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
[TBL] [Abstract][Full Text] [Related]
29. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
30. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
31. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J
Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870
[TBL] [Abstract][Full Text] [Related]
32. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
Dickson DW; Ksiezak-Reding H; Liu WK; Davies P; Crowe A; Yen SH
Acta Neuropathol; 1992; 84(6):596-605. PubMed ID: 1281953
[TBL] [Abstract][Full Text] [Related]
34. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
35. Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer's disease--comparison between Gallyas and Campbell-Switzer methods.
Uchihara T; Shibuya K; Nakamura A; Yagishita S
Acta Neuropathol; 2005 Mar; 109(3):299-305. PubMed ID: 15619127
[TBL] [Abstract][Full Text] [Related]
36. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
Uchihara T; Hara M; Nakamura A; Hirokawa K
Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524
[TBL] [Abstract][Full Text] [Related]
37. Regional quantitative study of formation process of neurofibrillary tangles in the hippocampus of non-demented elderly brains: comparison with late-onset Alzheimer's disease brains.
Takayama N; Iseki E; Yamamoto T; Kosaka K
Neuropathology; 2002 Sep; 22(3):147-53. PubMed ID: 12416553
[TBL] [Abstract][Full Text] [Related]
38. Distribution of neurofibrillary tangles in diffuse neurofibrillary tangles with calcification.
Ukai K; Shibayama H; Ishihara R; Ozaki N
Psychiatry Clin Neurosci; 2009 Oct; 63(5):646-51. PubMed ID: 19570148
[TBL] [Abstract][Full Text] [Related]
39. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
[TBL] [Abstract][Full Text] [Related]
40. Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression.
Damadzic R; Shuangshoti S; Giblen G; Herman MM
Acta Neuropathol; 2002 May; 103(5):488-94. PubMed ID: 11935265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
